###begin article-title 0
###xml 41 49 <span type="species:ncbi:9606">Children</span>
The Levels of Ghrelin, TNF-, and IL-6 in Children with Cyanotic and Acyanotic Congenital Heart Disease
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Background/Aim</italic>
###xml 284 305 284 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Materials and methods</italic>
###xml 484 491 484 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 795 805 795 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusion</italic>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
###xml 677 685 <span type="species:ncbi:9606">patients</span>
###xml 866 874 <span type="species:ncbi:9606">patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
Background/Aim. Ghrelin has effects on nutrient intake and growth. The cause of growth retardation in congenital heart disease is multifactorial. The aim of the present study is to investigate the ghrelin in congenital heart disease and the association of ghrelin with TNF- and IL-6. Materials and methods. We measured serum ghrelin, TNF-, and IL-6 levels using spesific immunoassay in 68 patients (47 acyanotic, 21 cyanotic with congenital heart disease) and in 25 control subjects. Results. In comparison to controls, serum ghrelin, TNF- levels were significantly higher in acyanotic patients and cyanotic patients with congenital heart disease (). In acyanotic and cyanotic patients with congenital heart disease, there was a positive correlation between ghrelin and TNF- (,  and , , resp.). Conclusion. Serum ghrelin levels is elevated in acyanotic and cyanotic patients with congenital heart disease. Increased ghrelin levels represents malnutrition and growth retardation in these patients. The relation of ghrelin with cytokines may be explained by the possible effect of chronic congestive heart failure and chronic shunt hypoxemia.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 165 170 <span type="species:ncbi:9606">human</span>
Ghrelin, a 28-amino-acide peptide, is a potent stimulator of growth hormone release that has been implicated in the control of food intake and energy homeostasis in human begins and rodents [1-5]. Ghrelin is mainly produced in the stomach. Ghrelin is not secreted into the gastrointestinal tract like digestive enzymes but into blood vessels to circulate throughout the body [6]. Ghrelin causes weight gain by increasing food intake and reducing fat use [7, 8]. Ghrelin has effects on nutrient intake and growth hormone (GH) release, subsequently on physical development and growth [9].
###end p 4
###begin p 5
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Tumor necrosis factor  (TNF-) and interleukin-6 (IL-6) are pleiotropic cytokines with numerous immunologic and metabolic actions [10, 11]. IL-6 is generally considered to be an important cytokine in the network of cytokines that regulate immune reactions and acute phase responses [12].
###end p 5
###begin p 6
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 119 126 <span type="species:ncbi:9606">Infants</span>
###xml 436 444 <span type="species:ncbi:9606">children</span>
###xml 664 672 <span type="species:ncbi:9606">children</span>
The relationship between congenital heart disease (CHD), malnutrition, and growth retardation is well documented [13]. Infants with congenital heart disease are prone to malnutrition for several reasons including decreased energy intake, increased energy requirements, or both. Different types of cardiac malformations can affect nutrition and growth to varying degrees [14]. Although nutritional and growth status were investigated in children with cyanotic and acyanotic heart disease, serum ghrelin levels have not been established. The objective of this study is to investigate and compare the functional role of ghrelin on the regulation of energy balance in children with cyanotic and acyanotic congenital heart disease and the association of ghrelin with TNF-, IL-6, that were not entirely confirmed in literature by now.
###end p 6
###begin title 7
2. MATERIAL AND METHODS
###end title 7
###begin title 8
2.1. Study population
###end title 8
###begin p 9
###xml 30 38 <span type="species:ncbi:9606">children</span>
###xml 62 70 <span type="species:ncbi:9606">children</span>
###xml 105 113 <span type="species:ncbi:9606">children</span>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 223 231 <span type="species:ncbi:9606">patients</span>
The study was conducted on 47 children with acyanotic CHD, 21 children with cyanotic CHD, and 25 healthy children. All patients' cardiac diagnoses were made on the basis of clinical and laboratory examinations. None of the patients had associated abnormalities or pulmonary hypertension. Body mass index (BMI) was calculated as the ratio of body weight (kg) and squared height (m). The local ethics committee approved the study protocol. Informed consents were obtained from the parents of the subjects.
###end p 9
###begin title 10
2.2. Laboratory investigation and immunoassay
###end title 10
###begin p 11
All blood samples were drawn at 08-09 am and stored -20degreesC until the procedure. Serum ghrelin, TNF-, and IL-6 levels were analyzed with ELISA kits (TNF-, IL-6 kit was purchased from Bio-Source International Inc. (Camarillo, Calif, USA); Ghrelin kit from Phoenix International, Inc, USA).
###end p 11
###begin title 12
2.3. Statistical analyses
###end title 12
###begin p 13
All data were analyzed by SPSS software, version 10.0 for Windows. Data were presented as mean +/- standard deviation. The given data were compared between groups using one-way ANOVA, followed by Post-hoc; Bonferroni test. Correlation between the parameters were explored with Spearman's correlation.  values less than .05 were considered statistically significant.
###end p 13
###begin title 14
3. RESULTS
###end title 14
###begin p 15
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 412 419 412 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
In 47 acyanotic patients, mean age was  months, in 21 cyanotic patients was  months and in 25 control subjects was  months. Age and anthropometric data of the patients and the control subjects are shown in Table 1. There was no significant difference between groups (the acyanotic patients, the cyanotic patients) in terms of mean age, weight, height, BMI. The specific cardiac lesions of patients are listed in Table 2.
###end p 15
###begin p 16
###xml 122 129 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 170 178 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
###xml 308 316 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 537 545 <span type="species:ncbi:9606">patients</span>
Serum ghrelin levels were significantly higher than in acyanotic and cyanotic groups compared to in the control group () (Table 3). Serum ghrelin levels in the acyanotic patients were significantly higher than in the cyanotic patients (). TNF- levels were significantly higher than in cyanotic and acyanotic patients with CHD compared to in the control groups (, , resp.). Serum TNF- values were higher in the acyanotic patients compared to the cyanotic patients with CHD (). Serum IL-6 levels were higher than in cyanotic and acyanotic patients with CHD compared to in the control groups (, , resp.).
###end p 16
###begin p 17
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(a)</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">1(b)</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(a)</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2(b)</xref>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
In both acyanotic and cyanotic groups, serum ghrelin levels were negatively correlated with BMI (,  and , , resp.) (Figures 1(a) and 1(b)). IL-6 and TNF- levels were not related to BMI in the acyanotic and cyanotic patients with CHD. Ghrelin levels were also correlated with TNF- in the acyanotic and cyanotic groups (,  and , , resp.) (Figures 2(a) and 2(b)). Ghrelin levels were not related to IL-6 in the acyanotic and cyanotic patients with CHD (,  and , , resp.).
###end p 17
###begin title 18
4. DISCUSSION
###end title 18
###begin p 19
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 298 306 <span type="species:ncbi:9606">Patients</span>
###xml 556 563 <span type="species:ncbi:9606">infants</span>
###xml 678 686 <span type="species:ncbi:9606">patients</span>
###xml 769 777 <span type="species:ncbi:9606">patients</span>
The cause of growth retardation in CHD is multifactorial. Inadequate caloric intake, malabsorption, and increased energy requirements caused by increased metabolism may all contribute. However, inadequate caloric intake appears to be the most important cause of growth failure in CHD [13, 15, 16]. Patients with acyanotic heart disease had a greater growth deficit in weight, and those with cyanotic heart disease had a greater growth deficit in stature as demonstrated by both decreased height and weight. Although growth impairment is most pronounced in infants with cyanotic CHD, growth failure does not correlate well with the degree of hypoxia. In this study, the cyanotic patients had a more pronounced retardation in both height and weight than in the acyanotic patients [13, 17].
###end p 19
###begin p 20
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 299 307 <span type="species:ncbi:9606">children</span>
###xml 343 351 <span type="species:ncbi:9606">children</span>
Ghrelin is accepted as a good marker of the nutritional state, mainly in situations of malnutrition, like anorexia nervosa, owing its fast recovery after weight gain [18]. The inverse correlation between ghrelin levels and BMI is well defined [9, 19]. We observed the mentioned correlation, both in children with cyanotic heart disease and in children with acyanotic heart disease.
###end p 20
###begin p 21
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 765 767 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
###xml 268 276 <span type="species:ncbi:9606">children</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
###xml 589 594 <span type="species:ncbi:9940">lambs</span>
###xml 871 879 <span type="species:ncbi:9606">patients</span>
###xml 951 959 <span type="species:ncbi:9606">patients</span>
Although the cyanotic patients had a more pronounced retardation in both height and weight than in the acyanotic patients, we found that serum ghrelin levels significantly elevated in the acyanotic patients than in the cyanotic patients (). Growth failure in cyanotic children has not been shown to be proportional to the severity of cyanosis, suggesting that multiple factors are involved in the pathogenesis of their growth disturbance [20]. Alteration of endocrine mediators of growth has been implicated as a possible mechanism of growth failure in cyanotic patients. Cyanotic newborn lambs have decreased levels of serum insulin-like growth factor I without a corresponding decrease in growth hormone or hepatic growth factor receptors [21]. Weintraub et al. [22] reported that while insulin-like growth factor I levels were linearly related to height and weight in patients with cyanotic lesions, no such correlation was found in their cyanotic patients. These studies suggest that chronic tissue hypoxia may have independent role in growth failure.
###end p 21
###begin p 22
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
###xml 563 571 <span type="species:ncbi:9606">children</span>
We found that serum TNF- significantly increased in the cyanotic patients and in the acyanotic patients. Similarly, serum IL-6 was increased in both groups but the change was more distinctive in the cyanotic patients. TNF- and IL-6 appear to be important cachectic process mediators, although this association is not completely established [23, 24]. Cardiac cachexia describes wasting primarily due to loss of lean body mass. Cachexia results in decreased muscle strength and function and compromised immune function [25, 26]. This syndrome is likely to occur in children who have chronic congestive heart failure, chronic shunt hypoxemia [27]. In addition to inadequate calorie and protein intake, there is evidence that this syndrome may be caused by circulating tumor necrosis factor, which stimulates catabolism [28].
###end p 22
###begin p 23
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
In the present study, ghrelin correlated to positively with TNF-, in acyanotic patients and cyanotic patients with CHD. The relation of ghrelin with TNF- raises the possibility of the direct effect of TNF- upon ghrelin or the impact of heart failure severity upon both ghrelin and TNF-. Nagaya et al. [29] have shown that plasma ghrelin level is increased in cachectic patients with congestive heart failure as a compensatory mechanism in response to anabolic-catabolic imbalance.
###end p 23
###begin p 24
###xml 73 81 <span type="species:ncbi:9606">patients</span>
###xml 173 181 <span type="species:ncbi:9606">patients</span>
In conclusion, serum ghrelin level is elevated in cyanotic and acyanotic patients with CHD. Increased ghrelin levels represents malnutrition and growth retardation in these patients. Additionally, the relation of ghrelin with cytokines may be explained by the possible effect of chronic congestive heart failure and chronic shunt hypoxemia.
###end p 24
###begin article-title 25
###xml 122 128 <span type="species:ncbi:9606">humans</span>
Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans
###end article-title 25
###begin article-title 26
###xml 44 50 <span type="species:ncbi:9606">humans</span>
Ghrelin-induced growth hormone secretion in humans
###end article-title 26
###begin article-title 27
###xml 42 46 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Ghrelin causes hyperphagia and obesity in rats
###end article-title 27
###begin article-title 28
###xml 44 49 <span type="species:ncbi:9606">human</span>
Circulating ghrelin levels are decreased in human obesity
###end article-title 28
###begin article-title 29
Ghrelin induces adiposity in rodents
###end article-title 29
###begin article-title 30
Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach
###end article-title 30
###begin article-title 31
A role for ghrelin in the central regulation of feeding
###end article-title 31
###begin article-title 32
###xml 80 88 <span type="species:ncbi:9606">children</span>
Relationships between fasting plasma ghrelin levels and metabolic parameters in children and adolescents
###end article-title 32
###begin article-title 33
###xml 34 42 <span type="species:ncbi:9606">children</span>
Ghrelin concentrations in healthy children and adolescents
###end article-title 33
###begin article-title 34
Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response
###end article-title 34
###begin article-title 35
Tumor necrosis factor: a pleiotropic cytokine and therapeutic target
###end article-title 35
###begin article-title 36
Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response
###end article-title 36
###begin article-title 37
Growth and nutrition
###end article-title 37
###begin article-title 38
Nutrition, growth, and gastrointestinal system: basic knowledge for pediatric cardiologist
###end article-title 38
###begin article-title 39
Calories count. Improved weight gain with dietary intervention in congenital heart disease
###end article-title 39
###begin article-title 40
Malnutrition and growth failure in cyanotic and acyanotic congenital heart disease with and without pulmonary hypertension
###end article-title 40
###begin article-title 41
Growth problems associated with congenital heart disease in infancy
###end article-title 41
###begin article-title 42
Physiopathological features and diagnostic utility of ghrelin protein in pediatrics
###end article-title 42
###begin article-title 43
###xml 110 118 <span type="species:ncbi:9606">children</span>
Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome
###end article-title 43
###begin article-title 44
###xml 41 47 <span type="species:ncbi:9606">people</span>
Growth and tissue abnormalities in young people with cyanotic congenital heart disease receiving systemic-pulmonary artery shunts
###end article-title 44
###begin article-title 45
###xml 87 92 <span type="species:ncbi:9940">lambs</span>
Decreased serum insulin-like growth factor-I associated with growth failure in newborn lambs with experimental cyanotic heart disease
###end article-title 45
###begin article-title 46
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Serum insulin-like growth factor I levels in patients congenital heart disease
###end article-title 46
###begin article-title 47
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
###end article-title 47
###begin article-title 48
Cachexia
###end article-title 48
###begin article-title 49
The nutrition implications of cardiac cachexia
###end article-title 49
###begin article-title 50
Cardiac cachexia
###end article-title 50
###begin article-title 51
###xml 57 65 <span type="species:ncbi:9606">children</span>
Nutritional conciderations in the prognosis treatment of children with congenital heart disease
###end article-title 51
###begin article-title 52
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure
###end article-title 52
###begin article-title 53
Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors
###end article-title 53
###begin p 54
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
(a) Correlation of ghrelin with BMI in acyanotic patients with CHD (, ). (b) Correlation of ghrelin with BMI in cyanotic patients with CHD (, ).
###end p 54
###begin p 55
###xml 50 58 <span type="species:ncbi:9606">patients</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
(a) Correlation of ghrelin with TNF- in acyanotic patients with CHD (, ). (b) Correlation of ghrelin with TNF- in cyanotic patients with CHD (, ).
###end p 55
###begin p 56
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Age and anthropometric data of the patients and the control subjects.
###end p 56
###begin p 57
###xml 17 25 <span type="species:ncbi:9606">patients</span>
Diagnosis of the patients.
###end p 57
###begin p 58
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Ghrelin, TNF-, and IL-6 levels of patients with CHD and control groups.
###end p 58
###begin p 59
 control: acyanotic group
###end p 59
###begin p 60
 control: cyanotic group
###end p 60
###begin p 61
 cyanotic: acyanotic group
###end p 61
###begin p 62
 control: acyanotic group
###end p 62
###begin p 63
 cyanotic: acyanotic group
###end p 63
###begin p 64
 control: cyanotic group
###end p 64

